chr5-37396434-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_018034.4(WDR70):c.356G>A(p.Gly119Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000473 in 1,613,864 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00042 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00048 ( 2 hom. )
Consequence
WDR70
NM_018034.4 missense
NM_018034.4 missense
Scores
4
11
4
Clinical Significance
Conservation
PhyloP100: 4.58
Genes affected
WDR70 (HGNC:25495): (WD repeat domain 70) Enables enzyme binding activity. Predicted to be involved in regulation of DNA double-strand break processing and regulation of histone H2B conserved C-terminal lysine ubiquitination. Predicted to be active in nucleus and site of double-strand break. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.08210832).
BS2
High Homozygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WDR70 | NM_018034.4 | c.356G>A | p.Gly119Asp | missense_variant | 5/18 | ENST00000265107.9 | |
WDR70 | NM_001345998.2 | c.353G>A | p.Gly118Asp | missense_variant | 5/18 | ||
WDR70 | NM_001345999.2 | c.290G>A | p.Gly97Asp | missense_variant | 4/17 | ||
WDR70 | XM_047417348.1 | c.287G>A | p.Gly96Asp | missense_variant | 4/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WDR70 | ENST00000265107.9 | c.356G>A | p.Gly119Asp | missense_variant | 5/18 | 1 | NM_018034.4 | P1 | |
WDR70 | ENST00000504564.1 | c.356G>A | p.Gly119Asp | missense_variant | 5/12 | 1 | |||
WDR70 | ENST00000511906.5 | n.370G>A | non_coding_transcript_exon_variant | 4/15 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152006Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
64
AN:
152006
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000565 AC: 142AN: 251304Hom.: 1 AF XY: 0.000523 AC XY: 71AN XY: 135830
GnomAD3 exomes
AF:
AC:
142
AN:
251304
Hom.:
AF XY:
AC XY:
71
AN XY:
135830
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000479 AC: 700AN: 1461740Hom.: 2 Cov.: 31 AF XY: 0.000479 AC XY: 348AN XY: 727164
GnomAD4 exome
AF:
AC:
700
AN:
1461740
Hom.:
Cov.:
31
AF XY:
AC XY:
348
AN XY:
727164
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000421 AC: 64AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.000417 AC XY: 31AN XY: 74380
GnomAD4 genome
AF:
AC:
64
AN:
152124
Hom.:
Cov.:
33
AF XY:
AC XY:
31
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
73
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 14, 2021 | The c.356G>A (p.G119D) alteration is located in exon 5 (coding exon 5) of the WDR70 gene. This alteration results from a G to A substitution at nucleotide position 356, causing the glycine (G) at amino acid position 119 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at